Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])

There are few data about the incidence, determinants, and clinical course of in-hospital repeat acute myocardial infarction (RE-AMI) after an index AMI. From June 1994 to June 1998, 22,613 patients with AMI as an index event were registered by the Maximal Individual Therapy in Acute Myocardial Infar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2001-05, Vol.87 (9), p.1039-1044
Hauptverfasser: DÖnges, Klaus, Schiele, Rudolf, Gitt, Anselm, Wienbergen, Harm, Schneider, Steffen, Zahn, Ralf, Grube, Rolf, Baumgärtel, Bernd, Glunz, Hans-Georg, Senges, Jochen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1044
container_issue 9
container_start_page 1039
container_title The American journal of cardiology
container_volume 87
creator DÖnges, Klaus
Schiele, Rudolf
Gitt, Anselm
Wienbergen, Harm
Schneider, Steffen
Zahn, Ralf
Grube, Rolf
Baumgärtel, Bernd
Glunz, Hans-Georg
Senges, Jochen
description There are few data about the incidence, determinants, and clinical course of in-hospital repeat acute myocardial infarction (RE-AMI) after an index AMI. From June 1994 to June 1998, 22,613 patients with AMI as an index event were registered by the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registries (MIR). Of these, 1,071 (4.7%) had a RE-AMI. For the index event, 9,143 patients (40.5%) were treated with thrombolysis, 1,707 (7.5%) with primary angioplasty, and 443 (2.0%) with a combination of both. Multivariate analysis showed that previous AMI (odds ratio [OR] 1.59; 95% confidence intervals [CI] 1.35 to 1.86), age >70 years (OR 1.57; 95% CI 1.36 to 1.81), diagnostic first electrocardiogram (OR 1.37; 95% CI 1.19 to 1.59), and female gender (OR 1.14; 95% CI 1.05 to 1.32) were independently associated with a higher incidence of RE-AMI. The incidence of RE-AMI was higher when patients received thrombolysis (OR 1.36; 95% CI 1.15 to 1.61), and it was lower when they underwent primary angioplasty (OR 0.74; 95% CI 0.53 to 1.03) or received β blockers (OR 0.84; 95% CI 0.72 to 0.97). Patients with RE-AMI had higher hospital mortality compared with those without RE-AMI (OR 4.35; 95% CI 3.83 to 4.95). Multivariate logistic regression analysis showed an independent association of RE-AMI with in-hospital death (OR 6.60; 95% CI 5.61 to 7.70), repeat revascularization (OR 2.91; 95% CI 2.42 to 3.50), low workload capacity on the bicycle ergometry test (OR 2.17; 95% CI 1.71 to 2.76), and ejection fraction 70 years, diagnostic first electrocardiogram, and female gender are independent determinants for RE-AMI. Thrombolysis is associated with a higher and β blockers with a lower incidence of RE-AMI. Once a RE-AMI occurs, it is a strong predictor of in-hospital mortality and morbidity.
doi_str_mv 10.1016/S0002-9149(01)01458-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70849351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914901014588</els_id><sourcerecordid>70849351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-cd676428f97d7c6c88dc1bcccbe48700af1667dc7bd8e5cafbce9f375164b9863</originalsourceid><addsrcrecordid>eNqFkltrFTEQx1fx0mP1IygBobTQ1eTsLXkSKV4OVAQvT6WE7GRiI7ubNcmWnm_f7J5D9UH0Kcnk958ZZv5Z9pzRV4yy-vVXSuk6F6wUx5SdUFZWPOf3sxXjjciZYMWDbHWHHGRPQviZnoxV9ePsgLGi5JUQq3uPNgNYjQPgKdEY0fd2UEMMp0QNmkBnBwuqI-AmH5A4QzzawSgP0bqB2CG_cmG0MSHKJHWKaLwhCqaIpN86UF7b9PmH5thjmLoYiPGuJ_EKyehch5poFdVcYQ716sb2i07ba6undE1hr8ZtCv0z_UVvo1eXu_6XVH_FPP6wIfotufi0-XJ58jR7aFQX8Nn-PMy-v3_37exjfv75w-bs7XkOZVXFHHTd1OWaG9HoBmrgXANrAaDFkjeUKsPqutHQtJpjBcq0gMIUTcXqshW8Lg6zo13e0btfE4YoexsAu04N6KYgG8pLUVQsgdUOBO9C8Gjk6NNE_FYyKmcDyMUAct6upEwuBpA86V7sC0xtj_q3ar_xBLzcAyqkzRqvkgHCHSdqsV76fLOjMA3j2qKXAezsEm09QpTa2f80cguU99QW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70849351</pqid></control><display><type>article</type><title>Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>DÖnges, Klaus ; Schiele, Rudolf ; Gitt, Anselm ; Wienbergen, Harm ; Schneider, Steffen ; Zahn, Ralf ; Grube, Rolf ; Baumgärtel, Bernd ; Glunz, Hans-Georg ; Senges, Jochen</creator><creatorcontrib>DÖnges, Klaus ; Schiele, Rudolf ; Gitt, Anselm ; Wienbergen, Harm ; Schneider, Steffen ; Zahn, Ralf ; Grube, Rolf ; Baumgärtel, Bernd ; Glunz, Hans-Georg ; Senges, Jochen ; for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups ; Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</creatorcontrib><description>There are few data about the incidence, determinants, and clinical course of in-hospital repeat acute myocardial infarction (RE-AMI) after an index AMI. From June 1994 to June 1998, 22,613 patients with AMI as an index event were registered by the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registries (MIR). Of these, 1,071 (4.7%) had a RE-AMI. For the index event, 9,143 patients (40.5%) were treated with thrombolysis, 1,707 (7.5%) with primary angioplasty, and 443 (2.0%) with a combination of both. Multivariate analysis showed that previous AMI (odds ratio [OR] 1.59; 95% confidence intervals [CI] 1.35 to 1.86), age &gt;70 years (OR 1.57; 95% CI 1.36 to 1.81), diagnostic first electrocardiogram (OR 1.37; 95% CI 1.19 to 1.59), and female gender (OR 1.14; 95% CI 1.05 to 1.32) were independently associated with a higher incidence of RE-AMI. The incidence of RE-AMI was higher when patients received thrombolysis (OR 1.36; 95% CI 1.15 to 1.61), and it was lower when they underwent primary angioplasty (OR 0.74; 95% CI 0.53 to 1.03) or received β blockers (OR 0.84; 95% CI 0.72 to 0.97). Patients with RE-AMI had higher hospital mortality compared with those without RE-AMI (OR 4.35; 95% CI 3.83 to 4.95). Multivariate logistic regression analysis showed an independent association of RE-AMI with in-hospital death (OR 6.60; 95% CI 5.61 to 7.70), repeat revascularization (OR 2.91; 95% CI 2.42 to 3.50), low workload capacity on the bicycle ergometry test (OR 2.17; 95% CI 1.71 to 2.76), and ejection fraction &lt;40% (OR 1.72; 95% CI 1.38 to 2.14) at discharge. Thus, RE-AMI occurs in 4.7% of patients after an AMI. Previous AMI, age &gt;70 years, diagnostic first electrocardiogram, and female gender are independent determinants for RE-AMI. Thrombolysis is associated with a higher and β blockers with a lower incidence of RE-AMI. Once a RE-AMI occurs, it is a strong predictor of in-hospital mortality and morbidity.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(01)01458-8</identifier><identifier>PMID: 11348599</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Adult ; Age Factors ; Aged ; Angioplasty ; Biological and medical sciences ; Cardiology. Vascular system ; Chi-Square Distribution ; Coronary heart disease ; Diabetes Complications ; Electrocardiography ; Female ; Germany - epidemiology ; Heart ; Hospital Mortality ; Humans ; Hypertension - complications ; Incidence ; Logistic Models ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - epidemiology ; Myocardial Infarction - therapy ; Predictive Value of Tests ; Recurrence ; Registries ; Risk Factors ; Sex Factors ; Thrombolytic Therapy</subject><ispartof>The American journal of cardiology, 2001-05, Vol.87 (9), p.1039-1044</ispartof><rights>2001 Excerpta Medica Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-cd676428f97d7c6c88dc1bcccbe48700af1667dc7bd8e5cafbce9f375164b9863</citedby><cites>FETCH-LOGICAL-c455t-cd676428f97d7c6c88dc1bcccbe48700af1667dc7bd8e5cafbce9f375164b9863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9149(01)01458-8$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=969286$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11348599$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DÖnges, Klaus</creatorcontrib><creatorcontrib>Schiele, Rudolf</creatorcontrib><creatorcontrib>Gitt, Anselm</creatorcontrib><creatorcontrib>Wienbergen, Harm</creatorcontrib><creatorcontrib>Schneider, Steffen</creatorcontrib><creatorcontrib>Zahn, Ralf</creatorcontrib><creatorcontrib>Grube, Rolf</creatorcontrib><creatorcontrib>Baumgärtel, Bernd</creatorcontrib><creatorcontrib>Glunz, Hans-Georg</creatorcontrib><creatorcontrib>Senges, Jochen</creatorcontrib><creatorcontrib>for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</creatorcontrib><creatorcontrib>Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</creatorcontrib><title>Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>There are few data about the incidence, determinants, and clinical course of in-hospital repeat acute myocardial infarction (RE-AMI) after an index AMI. From June 1994 to June 1998, 22,613 patients with AMI as an index event were registered by the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registries (MIR). Of these, 1,071 (4.7%) had a RE-AMI. For the index event, 9,143 patients (40.5%) were treated with thrombolysis, 1,707 (7.5%) with primary angioplasty, and 443 (2.0%) with a combination of both. Multivariate analysis showed that previous AMI (odds ratio [OR] 1.59; 95% confidence intervals [CI] 1.35 to 1.86), age &gt;70 years (OR 1.57; 95% CI 1.36 to 1.81), diagnostic first electrocardiogram (OR 1.37; 95% CI 1.19 to 1.59), and female gender (OR 1.14; 95% CI 1.05 to 1.32) were independently associated with a higher incidence of RE-AMI. The incidence of RE-AMI was higher when patients received thrombolysis (OR 1.36; 95% CI 1.15 to 1.61), and it was lower when they underwent primary angioplasty (OR 0.74; 95% CI 0.53 to 1.03) or received β blockers (OR 0.84; 95% CI 0.72 to 0.97). Patients with RE-AMI had higher hospital mortality compared with those without RE-AMI (OR 4.35; 95% CI 3.83 to 4.95). Multivariate logistic regression analysis showed an independent association of RE-AMI with in-hospital death (OR 6.60; 95% CI 5.61 to 7.70), repeat revascularization (OR 2.91; 95% CI 2.42 to 3.50), low workload capacity on the bicycle ergometry test (OR 2.17; 95% CI 1.71 to 2.76), and ejection fraction &lt;40% (OR 1.72; 95% CI 1.38 to 2.14) at discharge. Thus, RE-AMI occurs in 4.7% of patients after an AMI. Previous AMI, age &gt;70 years, diagnostic first electrocardiogram, and female gender are independent determinants for RE-AMI. Thrombolysis is associated with a higher and β blockers with a lower incidence of RE-AMI. Once a RE-AMI occurs, it is a strong predictor of in-hospital mortality and morbidity.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Angioplasty</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Chi-Square Distribution</subject><subject>Coronary heart disease</subject><subject>Diabetes Complications</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Heart</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Incidence</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Myocardial Infarction - therapy</subject><subject>Predictive Value of Tests</subject><subject>Recurrence</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Sex Factors</subject><subject>Thrombolytic Therapy</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkltrFTEQx1fx0mP1IygBobTQ1eTsLXkSKV4OVAQvT6WE7GRiI7ubNcmWnm_f7J5D9UH0Kcnk958ZZv5Z9pzRV4yy-vVXSuk6F6wUx5SdUFZWPOf3sxXjjciZYMWDbHWHHGRPQviZnoxV9ePsgLGi5JUQq3uPNgNYjQPgKdEY0fd2UEMMp0QNmkBnBwuqI-AmH5A4QzzawSgP0bqB2CG_cmG0MSHKJHWKaLwhCqaIpN86UF7b9PmH5thjmLoYiPGuJ_EKyehch5poFdVcYQ716sb2i07ba6undE1hr8ZtCv0z_UVvo1eXu_6XVH_FPP6wIfotufi0-XJ58jR7aFQX8Nn-PMy-v3_37exjfv75w-bs7XkOZVXFHHTd1OWaG9HoBmrgXANrAaDFkjeUKsPqutHQtJpjBcq0gMIUTcXqshW8Lg6zo13e0btfE4YoexsAu04N6KYgG8pLUVQsgdUOBO9C8Gjk6NNE_FYyKmcDyMUAct6upEwuBpA86V7sC0xtj_q3ar_xBLzcAyqkzRqvkgHCHSdqsV76fLOjMA3j2qKXAezsEm09QpTa2f80cguU99QW</recordid><startdate>20010501</startdate><enddate>20010501</enddate><creator>DÖnges, Klaus</creator><creator>Schiele, Rudolf</creator><creator>Gitt, Anselm</creator><creator>Wienbergen, Harm</creator><creator>Schneider, Steffen</creator><creator>Zahn, Ralf</creator><creator>Grube, Rolf</creator><creator>Baumgärtel, Bernd</creator><creator>Glunz, Hans-Georg</creator><creator>Senges, Jochen</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010501</creationdate><title>Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])</title><author>DÖnges, Klaus ; Schiele, Rudolf ; Gitt, Anselm ; Wienbergen, Harm ; Schneider, Steffen ; Zahn, Ralf ; Grube, Rolf ; Baumgärtel, Bernd ; Glunz, Hans-Georg ; Senges, Jochen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-cd676428f97d7c6c88dc1bcccbe48700af1667dc7bd8e5cafbce9f375164b9863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Angioplasty</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Chi-Square Distribution</topic><topic>Coronary heart disease</topic><topic>Diabetes Complications</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Heart</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Incidence</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Myocardial Infarction - therapy</topic><topic>Predictive Value of Tests</topic><topic>Recurrence</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Sex Factors</topic><topic>Thrombolytic Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DÖnges, Klaus</creatorcontrib><creatorcontrib>Schiele, Rudolf</creatorcontrib><creatorcontrib>Gitt, Anselm</creatorcontrib><creatorcontrib>Wienbergen, Harm</creatorcontrib><creatorcontrib>Schneider, Steffen</creatorcontrib><creatorcontrib>Zahn, Ralf</creatorcontrib><creatorcontrib>Grube, Rolf</creatorcontrib><creatorcontrib>Baumgärtel, Bernd</creatorcontrib><creatorcontrib>Glunz, Hans-Georg</creatorcontrib><creatorcontrib>Senges, Jochen</creatorcontrib><creatorcontrib>for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</creatorcontrib><creatorcontrib>Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DÖnges, Klaus</au><au>Schiele, Rudolf</au><au>Gitt, Anselm</au><au>Wienbergen, Harm</au><au>Schneider, Steffen</au><au>Zahn, Ralf</au><au>Grube, Rolf</au><au>Baumgärtel, Bernd</au><au>Glunz, Hans-Georg</au><au>Senges, Jochen</au><aucorp>for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</aucorp><aucorp>Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2001-05-01</date><risdate>2001</risdate><volume>87</volume><issue>9</issue><spage>1039</spage><epage>1044</epage><pages>1039-1044</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>There are few data about the incidence, determinants, and clinical course of in-hospital repeat acute myocardial infarction (RE-AMI) after an index AMI. From June 1994 to June 1998, 22,613 patients with AMI as an index event were registered by the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registries (MIR). Of these, 1,071 (4.7%) had a RE-AMI. For the index event, 9,143 patients (40.5%) were treated with thrombolysis, 1,707 (7.5%) with primary angioplasty, and 443 (2.0%) with a combination of both. Multivariate analysis showed that previous AMI (odds ratio [OR] 1.59; 95% confidence intervals [CI] 1.35 to 1.86), age &gt;70 years (OR 1.57; 95% CI 1.36 to 1.81), diagnostic first electrocardiogram (OR 1.37; 95% CI 1.19 to 1.59), and female gender (OR 1.14; 95% CI 1.05 to 1.32) were independently associated with a higher incidence of RE-AMI. The incidence of RE-AMI was higher when patients received thrombolysis (OR 1.36; 95% CI 1.15 to 1.61), and it was lower when they underwent primary angioplasty (OR 0.74; 95% CI 0.53 to 1.03) or received β blockers (OR 0.84; 95% CI 0.72 to 0.97). Patients with RE-AMI had higher hospital mortality compared with those without RE-AMI (OR 4.35; 95% CI 3.83 to 4.95). Multivariate logistic regression analysis showed an independent association of RE-AMI with in-hospital death (OR 6.60; 95% CI 5.61 to 7.70), repeat revascularization (OR 2.91; 95% CI 2.42 to 3.50), low workload capacity on the bicycle ergometry test (OR 2.17; 95% CI 1.71 to 2.76), and ejection fraction &lt;40% (OR 1.72; 95% CI 1.38 to 2.14) at discharge. Thus, RE-AMI occurs in 4.7% of patients after an AMI. Previous AMI, age &gt;70 years, diagnostic first electrocardiogram, and female gender are independent determinants for RE-AMI. Thrombolysis is associated with a higher and β blockers with a lower incidence of RE-AMI. Once a RE-AMI occurs, it is a strong predictor of in-hospital mortality and morbidity.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11348599</pmid><doi>10.1016/S0002-9149(01)01458-8</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2001-05, Vol.87 (9), p.1039-1044
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_70849351
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adrenergic beta-Antagonists - therapeutic use
Adult
Age Factors
Aged
Angioplasty
Biological and medical sciences
Cardiology. Vascular system
Chi-Square Distribution
Coronary heart disease
Diabetes Complications
Electrocardiography
Female
Germany - epidemiology
Heart
Hospital Mortality
Humans
Hypertension - complications
Incidence
Logistic Models
Male
Medical sciences
Middle Aged
Myocardial Infarction - epidemiology
Myocardial Infarction - therapy
Predictive Value of Tests
Recurrence
Registries
Risk Factors
Sex Factors
Thrombolytic Therapy
title Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [mitra], and the myocardial infarction registry [MIR])
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T20%3A55%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence,%20determinants,%20and%20clinical%20course%20of%20reinfarction%20in-hospital%20after%20index%20acute%20myocardial%20infarction%20(results%20from%20the%20pooled%20data%20of%20the%20maximal%20individual%20therapy%20in%20acute%20myocardial%20infarction%20%5Bmitra%5D,%20and%20the%20myocardial%20infarction%20registry%20%5BMIR%5D)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=D%C3%96nges,%20Klaus&rft.aucorp=for%20the%20Maximal%20Individual%20Therapy%20in%20Acute%20Myocardial%20Infarction%20(MITRA)%20and%20Myocardial%20Infarction%20Registry%20(MIR)%20Study%20Groups&rft.date=2001-05-01&rft.volume=87&rft.issue=9&rft.spage=1039&rft.epage=1044&rft.pages=1039-1044&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(01)01458-8&rft_dat=%3Cproquest_cross%3E70849351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70849351&rft_id=info:pmid/11348599&rft_els_id=S0002914901014588&rfr_iscdi=true